DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Steffel J, Eikelboom JW, Anand SS, Shestakovska O, Yusuf S, Fox KAA.
The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease.
Circulation 2020;
142 (01) 40-48 [Erratum in: Circulation. 2020 Jul 7;142(1):e23. PMID: 32436455]
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.